- Home
- BCLI vs GWAV Comparison
BCLI vs GWAV Comparison
Compare BCLI & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- GWAV
- Stock Information
- Founded
- BCLI 2000
- GWAV 2002
- Country
- BCLI United States
- GWAV United States
- Employees
- BCLI N/A
- GWAV N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- GWAV Packaged Foods
- Sector
- BCLI Health Care
- GWAV Consumer Staples
- Exchange
- BCLI Nasdaq
- GWAV Nasdaq
- Market Cap
- BCLI 9.9M
- GWAV 11.5M
- IPO Year
- BCLI N/A
- GWAV N/A
- Fundamental
- Price
- BCLI $1.21
- GWAV $0.24
- Analyst Decision
- BCLI Strong Buy
- GWAV
- Analyst Count
- BCLI 1
- GWAV 0
- Target Price
- BCLI $30.00
- GWAV N/A
- AVG Volume (30 Days)
- BCLI 35.3K
- GWAV 2.0M
- Earning Date
- BCLI 03-31-2025
- GWAV 05-19-2025
- Dividend Yield
- BCLI N/A
- GWAV N/A
- EPS Growth
- BCLI N/A
- GWAV N/A
- EPS
- BCLI N/A
- GWAV N/A
- Revenue
- BCLI N/A
- GWAV $33,918,197.00
- Revenue This Year
- BCLI $170.09
- GWAV N/A
- Revenue Next Year
- BCLI N/A
- GWAV N/A
- P/E Ratio
- BCLI N/A
- GWAV N/A
- Revenue Growth
- BCLI N/A
- GWAV 3.89
- 52 Week Low
- BCLI $1.05
- GWAV $0.22
- 52 Week High
- BCLI $11.25
- GWAV $44.55
- Technical
- Relative Strength Index (RSI)
- BCLI 30.68
- GWAV 36.26
- Support Level
- BCLI $1.12
- GWAV $0.22
- Resistance Level
- BCLI $1.59
- GWAV $0.29
- Average True Range (ATR)
- BCLI 0.11
- GWAV 0.03
- MACD
- BCLI -0.02
- GWAV -0.00
- Stochastic Oscillator
- BCLI 17.31
- GWAV 15.36
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About GWAV Greenwave Technology Solutions Inc.
Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company's products are selling ferrous metal, which is used in the recycling and production of finished steel. It is categorized into heavy melting steel, plate and structural, and shredded scrap. and it also processes nonferrous metals such as aluminum, copper, stainless steel, nickel, brass, titanium, alloys, and mixed metal products.